J64690 Cdc2-Like Kinase Inhibitor, TG003
SDS
| Stock No. | Size | Price ($) | Quantity | Availability |
|---|---|---|---|---|
| J64690-#0 | 5mg | 76.20 |
|
|
| J64690-MF | 50mg | 509.00 |
|
|
Cdc2-Like Kinase Inhibitor, TG003
Chemical Properties
Applications
Cdc2-Like Kinase Inhibitor, TG003 is a benzothiazole agent that acts as a specific and ATP-competitive inhibitor of Clk family members. Reports show that TG003 modifies the regulation of alternative splicing modulated by phosphorylation of SR proteins in vitro, and rescues defects in the development of Xenopus caused by an overabundance of Clk activity.
Notes
Literature References
Yasushi Ogawa.; Yosuke Nonaka.; Toshiyasu Goto.; Eriko Ohnishi.; Toshiyuki Hiramatsu.; Isao Kii.; Miyo Yoshida.; Teikichi Ikura.; Hiroshi Onogi.; Hiroshi Shibuya.; Takamitsu Hosoya.; Nobutoshi Ito.; Masatoshi Hagiwara. Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A. Nature Communications. 2010, 1 86.
GHS Hazard and Precautionary Statements
Hazard Statements: H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Precautionary Statements: P261-P280a-P305+P351+P338-P304+P340-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.
Other References
Chemicals
Life Science
Metals & Materials
Catalysts
